Haber, Michelle (1956 - )

Summary

Michelle Haber in recognised internationally for her research into the causes and treatment of paediatric cancers, particularly neuroblastoma and acute lymphoblastic leukaemia. Her work focuses on understanding the basis of drug resistance and the development of targeted therapies to improve treatment outcomes. In 1984 Haber was one of the first scientists to be appointed to the Children's Cancer Institute Australia, becoming Executive Director in 2003. She is active in international organisations for research and treatment of neuroblastoma, including serving as President of the Advances in Neuroblastoma Research Association. Haber has received numerous awards for her research.

Details

"Michelle Haber is a world-renowned authority in the field of childhood cancer research and a key leader of the Australian biomedical research community. She has made fundamental discoveries in the area of drug resistance in neuroblastoma, and has pioneered molecular diagnostics and precision medicine for Australian children with leukaemia and other high-risk cancers. Haber's work has had a major impact on the global research community, and been translated into new therapeutics and changed models of care for Australian child cancer sufferers." [from https://www.science.org.au/profile/michelle-haber 2/11/2023]

Chronology

1961

Life event - Migrated to Australia with her family

1978

Education - BSc (hons) University of New South Wales

1984

Education - PhD, University of New South Wales

1984 - 1992

Career position - Scientist, Children's Cancer Institute Australia

1992 - 1996

Career position - Senior Research Fellow, Children's Cancer Institute Australia

1994 -

Career position - Member, Biology Committee, International Neuroblastoma Staging System (INNS) and International Neuroblastoma Risk Group (INRG)

1996 - 2000

Career position - Principal Research Fellow, Children's Cancer Institute Australia

1996 - 2000

Career position - Associate Professor, School of Paediatrics, University of New South Wales

1998 -

Career position - Head, Experimental Therapeutics Program, University of New South Wales

1999 - 2000

Career position - Acting Director, Children's Cancer Institute Australia

2000 -

Career position - Conjoint Professor, School of Women's and Children's Health, University of New South Wales

2000 - 2003

Career position - Director, Children's Cancer Institute Australia

2003 -

Career position - Board Member, Children's Cancer Institute Australia

2003 -

Career position - Executive Director, Children's Cancer Institute Australia

2006 - 2014

Career position - Member, Steering Committee, International Advances in Neuroblastoma Research Association

2007

Award - Member of the Order of Australia (AM) for service to science in the field of research into childhood cancer, to scientific education, and to the community

2008

Career position - Member, Research Fellowship Panel, National Health and Medical Research Council

2008

Award - DSc honoris causa, University of New South Wales

2008 - 2012

Career position - President, Advances of Neuroblastoma Research Association

2011

Award - Award for Biomedical Sciences and Engineering, New South Wales Science and Engineering Awards

2012

Award - Cancer Institute NSW Premier's Award for Excellence in Translational Cancer Research

2014

Award - Cancer Institute N.S.W. Premier's Award for Outstanding Cancer Researcher of the Year

2015 -

Award - Inaugural Fellow, Australian Academy of Health and Medical Sciences

2022 -

Award - Fellow, Australian Academy of Science

Related entries

Published resources

Resources

• Member (AM) in the General Division of the Order of Australia [Australia Day 2007], Governor General's Office, Canberra, 2007. https://web.archive.org/web/20180412034021/https://www.gg.gov.au/sites/default/files/files/honours/ad/ad2007/medianotesAM%28H-Z%29.pdf. Details
• 'Haber, Michelle (1956 - )', Fellows of the Academy, Australian Academy of Science, 2019, https://www.science.org.au/profile/michelle-haber. Details